The effect of ticagrelor on serum hs-CRP and ESM-1 and short-term prognosis of patients with acute ST-segment elevation myocardial infarction
Author:
Affiliation:

1.Department of Cardiology, Xuzhou Central Hospital, the Affiliated Hospital of Southeast University, Xuzhou, Jiangsu 221009, China;2.Department of Cardiology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China;3.Department of Geriatrics, Changhai Hospital of the Second Military Medical University, Shanghai 200433, China;4.Department of Cardiology, People's Hospital of Ganzhou, Ganzhou, Jiangxi 341000, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [16]
  • | | | |
  • Comments
    Abstract:

    Aim To observe the changes of serum high sensitivity C-reactive protein (hs-CRP) and endothelial cell-specific molecule-1 (ESM-1) levels and short-term prognosis of ticagrelor in treatment of patients with acute ST-segment elevation myocardial infarction (STEMI). Methods A total of 107 patients with acute STEMI were selected, all of whom were treated in department of cardiology in our hospital for new onset of symptoms and received emergency PCI successfully. The patients were divided into two groups according to the application of ticagrelor in dual antiplatelet therapy (DAPT):ticagrelor group (n=54) and clopidogrel group (n=53). Two groups of patients were observed for changes of hs-CRP and ESM-1 immediately after admission as well as 24 h, 4 d and 7 d after medication, their correlation, and influences of ticagrelor on short-term prognosis of patients with acute STEMI. Results Hs-CRP and ESM-1 of the two groups of patients were obviously elevated at 24 h after medication, and there were statistical differences (P<0.05), and hs-CRP and ESM-1 of the two groups of patients were decreasing at 4 d and 7 d, with statistically significant differences (P<0.05); ESM-1 was increased with the increase of hs-CRP, showing a positive correlation between ESM-1 and hs-CRP (r=0.535, P<0.001), there were no statistical differences in comparison between the two groups in incidences of ischemic end event, hemorrhagic event and total adverse events (P>0.05). Conclusions Ticagrelor can more quickly reduce the cell inflammation and stabilize endothelium in treatment of STEMI patients, so as to improve the stability of atherosclerotic plaque, reduce the formation of thrombus and ischemic end events, but it does not increase the risk of bleeding, which is worth of clinical application.

    Reference
    [1] Armstrong PW, Gershlick AH, Goldstein P, et al.Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.N Engl J Med, 3,8(15):1 379-387.
    [2] Pedersen F, Butrymovich V, Kelbk H, et al.Short- and long-term cause of death in patients treated with primary PCI for STEMI.J Am Coll Cardiol, 4,4(20):2 101-108.
    [3] Gul M, Uslu N, Satilmisoglu H, et al.When should fQRS be evaluated as a noninvasive prognostic marker in patients undergoing primary PCI with STEMI.Ann Noninvasive Electrocardiol, 5,0(2):200-201.
    [4] Thygesen K, Alpert JS, Jaffe AS, et al.Third universal definition of myocardial infarction.J Am Coll Cardiol, 2,0(16):1 581-598.
    [5] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志, 0,8(8):675-690.
    [6] James S, Akerblom A, Cannon CP, et al.Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes:Rationale, design, and baseline characteristics of the PLATelet inhibition and patient outcomes (PLATO) trial.Am Heart J, 9,7(4):599-605.
    [7] Diehl P, Olivier C, Halscheid C, et al.Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.Basic Res Cardiol, 0,5(3):379-387.
    [8] Webster CM, Hokari M, McManus A, et al.Microglial P2Y12 deficiency/inhibition protects against brain ischemia.PLoS One, 3,8(8):e70927.
    [9] Taniguchi H, Momiyama Y, Ohmori R, et al.Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease.Atherosclerosis, 5,8(1):173-177.
    [10] Kirbis S, Breskvar UD, Sabovic M, et al.Inflammation markers in patients, with coronary artery disease-comparison of intracoronary and systemic levels.Wien Klin Wochenschr, 0,2(Suppl 2):31-34.
    [11] Béchard D, Gentina T, Delehedde M, et al.Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity.J Biol Chem, 1,6(51):48 341-349.
    [12] Menon P, Kocher ON, Aird WC.Endothelial cell specific molecule-1 (ESM-1), a novel secreted proteoglycan stimulates vascular smooth muscle cell proliferation and migration.Circulation, 1,4(21):A15455.
    [13] Kose M, Emet S, Akpinar TS, et al.Serum endocan level and the severity of coronary artery disease:a pilot study.Angiology, 5,6(8):727-731.
    [14] Tadzic R, Mihalj M, Vcev A, et al.The effects of arterial blood pressure reduction on endocan and soluble endothelial cell adhesion molecules (CAMs) and CAMs ligands expression in hypertensive patients on Ca-channel blocker therapy.Kidney Blood Press Res, 3,7(2-3):103-115.
    [15] Qiu C, Sui J, Zhang Q , et al.Relationship of endothelial cell-specific molecule 1 level in stress hyperglycemia patients with acute ST-segment elevation myocardial infarction:a pilot study.Angiology, 6,7(9):829-834.
    [16] Wallentin L, Becker RC, Budaj A, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes.N Engl J Med, 9,1(11):1 045-057.
    Related
    Cited by
Get Citation

WEI Peng, YANG Xiang-Jun, FU Qiang, LU Wen, LING Lin, ZONG Bin, ZHANG Wen-Jun, QIU Chong-Rong, BAI Jie. The effect of ticagrelor on serum hs-CRP and ESM-1 and short-term prognosis of patients with acute ST-segment elevation myocardial infarction[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2017,25(3):264-268.

Copy
Share
Article Metrics
  • Abstract:1262
  • PDF: 1030
  • HTML: 0
  • Cited by: 0
History
  • Received:July 05,2016
  • Revised:December 06,2016
  • Online: March 28,2017
Article QR Code